Pyelonephritis and complicated UTI: workup and management
Pyelonephritis: fever, flank pain or costovertebral angle tenderness with pyuria and bacteriuria. Send urine culture before antibiotics, look for obstruction or abscess in patients who are septic or not improving, and choose empiric therapy by severity and local resistance.
Working diagnosis
Adult · US guidelines
Draft · awaiting physician review
01Orient
What's new in the evidence
- IDSA 2025 complicated UTI guideline: cUTI means infection beyond the bladder (fever, flank pain, bacteremia, hemodynamic instability), whatever the host
- Durations if improving: 5–7 days of a fluoroquinolone or 7 days of a non-fluoroquinolone (including oral beta-lactams at adequate doses)
- Gram-negative bacteremia from a urinary source: 7 days total with oral step-down allowed (supported by BALANCE, 2025)
- 10–14 days only if acute bacterial prostatitis is suspected; count days from the first effective dose
Differential diagnoses
- Acute pyelonephritis
- Obstructed infected kidney (infected stone) (can't miss: needs urgent drainage)
- Renal or perinephric abscess, emphysematous pyelonephritis
- Urosepsis
- Nephrolithiasis without infection
- Appendicitis, diverticulitis, cholecystitis
- PID or ectopic pregnancy (can't miss)
- Prostatitis in men
02Assess
Risk scores and decision tools
- qSOFA/SOFA for sepsis
- Risk factors for resistance: prior resistant organism, antibiotics in 3 months, recent hospitalization, travel
- Local antibiogram for empiric choice in sepsis
Key history questions
- Dysuria, frequency, flank pain, fever, rigors
- Prior UTIs and organisms; recent antibiotics
- Catheter, stones, urological procedures
- Pregnancy possibility
- Diabetes, immunosuppression
Examination findings
- Fever, tachycardia, hypotension
- Costovertebral angle tenderness
- Abdominal and pelvic exam as indicated
- Prostate tenderness in men (gentle)
03Investigate
Initial investigations
- Urinalysis and urine culture before antibiotics
- CBC, BMP, lactate if unwell
- Blood cultures if septic or admitted
- Pregnancy test
Advanced investigations
- Renal ultrasound or CT if sepsis, suspected obstruction, stones, or no improvement after 48–72 hours
- CT (non-contrast for stones; contrast for abscess)
04Treat
Immediate management
- Septic shock: sepsis bundle and urgent imaging for obstruction
- Obstructed infected kidney: emergency decompression (stent or nephrostomy)
First-line treatment
- Sepsis: third/fourth-generation cephalosporin, piperacillin-tazobactam, carbapenem or fluoroquinolone chosen by resistance risk and local antibiogram
- Inpatient without sepsis: ceftriaxone 1 g IV daily (broaden if ESBL risk)
- Outpatient, if local fluoroquinolone resistance ≤10%: ciprofloxacin 500 mg twice daily or levofloxacin 750 mg daily
- Durations: 5–7 days fluoroquinolone or 7 days non-fluoroquinolone; 7 days for gram-negative bacteremia; 10–14 days if prostatitis
Second-line treatment
- ESBL risk or prior ESBL: carbapenem (e.g., ertapenem)
- Pseudomonas risk: cefepime or piperacillin-tazobactam
- Catheter-associated: replace the catheter and culture from the new one
Specialist referrals
- Urology for obstruction, abscess or emphysematous pyelonephritis
- Obstetrics if pregnant
05Disposition
Admission criteria
- Sepsis, vomiting or unable to take oral medication
- Obstruction, abscess, pregnancy
- Significant comorbidity or failed outpatient therapy
Safe discharge criteria
- Tolerating oral antibiotics and fluids
- Hemodynamically stable, not pregnant
- Reliable 48–72 hour follow-up
Follow-up timing
- Review at 48–72 hours; check culture results
Patient instructions
- Finish the full course
- Return for persistent fever after 72 hours, vomiting or worsening pain
Monitoring
- Fever curve, renal function, culture-guided de-escalation
Clinical pearls and pitfalls
- Asymptomatic bacteriuria should not be treated (except pregnancy and before urologic procedures)
- Avoid nitrofurantoin and fosfomycin for pyelonephritis; they do not reach kidney tissue reliably
- Fever can persist for 48–72 hours even with effective therapy
RefGuidelines and landmark evidence
- GuidelineIDSA/ESCMID – Acute Uncomplicated Cystitis and Pyelonephritis in Women (2010 update)PubMed
- GuidelineIDSA – 2025 Guideline on the Management and Treatment of Complicated Urinary Tract InfectionsPubMed
- Trial7 vs 14 days of antibiotics for gram-negative bacteremia (Yahav et al., 2019)PubMed
- TrialBALANCE: 7 vs 14 days of antibiotics for bloodstream infection (2025)PubMed
For education only. Typical adult starting points; confirm doses against renal function, allergies, interactions and your institution's protocols. Not a substitute for clinical judgment or senior review.